Georgetown Lombardi Comprehensive Cancer Center

Washington, District of Columbia 20007

Use our guide to learn which trials are right for you!

We've found
9 trials
at this facility
Cancer Clinical Trial
JTX-2011 Alone and in Combination With Anti-PD-1 or Anti-CTLA-4 in Subjects With Advanced and/or Refractory Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 2 Multicenter Study of Axicabtagene Ciloleucel in Subjects With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Trial of TTI-622 in Patients With Advanced Relapsed or Refractory Lymphoma or Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Status: Enrolling
Updated: 4/4/2013
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/18/2015
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Selinexor in Patients With Advanced Thymic Epithelial Tumor Progressing After Primary Chemotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Malignant Melanoma Clinical Trial
Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma
Status: Enrolling
Updated: 5/25/2016
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Oncology Clinical Trial
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials
Breast Cancer Clinical Trial
ASCENT-Study of Sacituzumab Govitecan in Refractory/Relapsed Triple-Negative Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Georgetown Lombardi Comprehensive Cancer Center
mi
from
Washington DC,
Click here to add this to my saved trials